FDA NDC Directory · JSON-LD · Markdown

Zavesca

NDC 66215-201 · HUMAN PRESCRIPTION DRUG · CAPSULE

Generic namemiglustat
Labeler / ManufacturerActelion Pharmaceuticals US, Inc.
Marketing categoryNew Drug Application (innovator) · App NDA021348
Dosage form / routeCAPSULE · ORAL
Active ingredientsMIGLUSTAT (100 mg/1)
Marketing started20030731
Package count1

External sources

Source: openFDA. Public-domain (CC0).